Oncotarget cover image

HER3: A Vital Target in Cancer Treatment

Oncotarget

00:00

HER3 Overactivation as a Resistance Mechanism in Cancer Cells

This chapter explores how HER3 overactivation can serve as a resistance mechanism in cancer cells, potentially leading to the overexpression of EGFR or HER2. The speakers emphasize the need for further research on alternative activation mechanisms and the development of combination therapies to combat resistance.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app